|
Novo Nordisk will now run a Phase III trial for zaltenibart in the rare blood disorder, PNH.
|
 |
|
The investment is part of AstraZeneca’s wider $50bn outlay to bolster manufacturing in the US.
|
|
|
The partnership is in accordance with a White House Executive Order aimed at enhancing affordable access
|
|
|
Adcytherix has set a target to file for an IND and clinical trial applications in Canada, the UK, and the EU by the end of 2025.
|
|
|
With a legacy rooted in global scientific excellence, Sweden is quietly building one of Europe’s most dynamic biotech ecosystems - despite lacking a big pharma anchor and facing persistent funding gaps.
|
|
